Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes

被引：3
|
作者：
Mahdi, Ali J. [1 ]
Gosrani, Deepan [1 ]
Chakraborty, Mallinath [2 ]
Rees, Alexandra [3 ]
Conner, Christine [3 ]
Wilson, Keith [1 ]
Rayment, Rachel [1 ]
Alvares, Caroline [1 ]
机构：
[1] Univ Hosp Wales, Dept Haematol, Cardiff, S Glam, Wales
[2] Univ Hosp Wales, Reg Neonatal Intens Care Unit, Cardiff, S Glam, Wales
[3] Univ Hosp Wales, Dept Obstet & Gynaecol, Cardiff, S Glam, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 180卷 / 04期
关键词：
leukaemia; pregnancy; acute leukaemia; ACUTE MYELOID-LEUKEMIA;
D O I：
10.1111/bjh.14417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [21] Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia
    Bourque, S. L.
    Dolinsky, V. W.
    Dyck, J. R. B.
    Davidge, S. T.
    PLACENTA, 2012, 33 (05) : 449 - 452
  • [22] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Comment
    White, Tacey
    Williams, Amy
    DeSesso, John M.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 124 - 125
  • [23] Risks of Selected Fetal Adverse Pregnancy Outcomes at Advance Maternal Age
    Yasmeen, Saadia
    Sumayya
    Saleem, Javeria
    Liaqat, Jawairiah
    Pervaiz, Nadia
    Rehman, Fatima
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (08): : 2468 - 2471
  • [24] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Response
    Sweeting, J. Nicole
    Wells, Peter G.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 126 - 127
  • [25] Insulin glargine use in pregnancy is not associated with adverse maternal or fetal outcomes
    Gallen, Ian W.
    Jaap, Alan J.
    DIABETES, 2006, 55 : A417 - A417
  • [26] Chloroquine or hydroxychloroquine use during pregnancy not associated with adverse fetal outcomes
    Reactions Weekly, 2020, 1833 (1) : 3 - 3
  • [27] Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes: a response
    Becking, Ellis C.
    Sistermans, Erik A.
    Bekker, Mireille N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (01) : e56 - e56
  • [28] Are increased fetal movements during pregnancy a predictor of neonatal adverse outcomes?
    Cohen, Gal
    Bogin, Rona
    Schreiber, Hanoch
    Shechter-Maor, Gil
    Cohen, Ido
    Biron-Shental, Tal
    Daykan, Yair
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (02) : 349 - 351
  • [29] Fetal isolated short femur in the second trimester and adverse pregnancy outcomes
    Ozlu, Tulay
    Ozcan, Tulin
    PRENATAL DIAGNOSIS, 2013, 33 (11) : 1063 - 1069
  • [30] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Response
    Fejzo, Marlena
    MacGibbon, Kimber
    Mullin, Patrick
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 123 - 123
12345